Detalles de la búsqueda
1.
Association of Moderate-Risk Breast Cancer Genes with Contralateral Prophylactic Mastectomy and Bilateral Disease.
Ann Surg Oncol
; 30(12): 6990-6999, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37661222
2.
Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma.
Mod Pathol
; 33(11): 2221-2232, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32612248
3.
ASO Visual Abstract: Association of Moderate-Risk Breast Cancer Genes with Contralateral Prophylactic Mastectomy and Bilateral Disease.
Ann Surg Oncol
; 30(13): 8484-8485, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37728824
4.
Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness.
Gynecol Oncol
; 132(2): 287-91, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24333355
5.
Real-World Evidence on the Use of Endocrine Therapy for Ductal Carcinoma In Situ in Patients Treated With Breast-Conserving Surgery Followed by Postoperative Radiation Therapy: A Brazilian Retrospective Cohort Study.
Clin Breast Cancer
; 23(8): e499-e506, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37758557
6.
Incorporation of TILs in daily breast cancer care: how much evidence can we bear?
Virchows Arch
; 480(1): 147-162, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35043236
7.
Germline molecular data in hereditary breast cancer in Brazil: Lessons from a large single-center analysis.
PLoS One
; 16(2): e0247363, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33606809
8.
Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) after Progression on Trastuzumab.
Case Rep Oncol
; 11(2): 252-257, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29867432
Resultados
1 -
8
de 8
1
Próxima >
>>